Patents by Inventor Caleb Bell

Caleb Bell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11183365
    Abstract: An ion source for an ion implantation system has a plurality of arc chambers. The ion source forms an ion beam from a respective one of the plurality of arc chambers based on a position of the respective one of the plurality of arc chambers with respect to a beamline. The arc chambers are coupled to a carrousel that translates or rotates the respective one of the plurality of arc chambers to a beamline position associated with the beamline. One or more of the plurality of arc chambers can have at least one unique feature, or two or more of the plurality of arc chambers can be generally identical to one another.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: November 23, 2021
    Assignee: AXCELIS TECHNOLOGIES, INC.
    Inventors: Joshua Max Abeshaus, Neil Bassom, Camilla Lambert, Caleb Wisch, Kyle Hinds, Caleb Bell
  • Publication number: 20200335302
    Abstract: An ion source for an ion implantation system has a plurality of arc chambers. The ion source forms an ion beam from a respective one of the plurality of arc chambers based on a position of the respective one of the plurality of arc chambers with respect to a beamline. The arc chambers are coupled to a carrousel that translates or rotates the respective one of the plurality of arc chambers to a beamline position associated with the beamline. One or more of the plurality of arc chambers can have at least one unique feature, or two or more of the plurality of arc chambers can be generally identical to one another.
    Type: Application
    Filed: April 16, 2020
    Publication date: October 22, 2020
    Inventors: Joshua Max Abeshaus, Neil Bassom, Camilla Lambert, Caleb Wisch, Kyle Hinds, Caleb Bell
  • Patent number: 9657275
    Abstract: The present invention is directed generally to eukaryotic host cells comprising artificial endosymbionts and methods of introducing artificial endosymbionts into eukaryotic host cells. The invention provides artificial endosymbionts that introduce a phenotype to host cells that is maintained in daughter cells. The invention additionally provides eukaryotic host cells containing magnetotactic bacteria.
    Type: Grant
    Filed: September 12, 2016
    Date of Patent: May 23, 2017
    Assignee: Bell Biosystems, Inc.
    Inventors: Caleb Bell, III, Alexey Bazarov
  • Publication number: 20160376561
    Abstract: The present invention is directed generally to eukaryotic host cells comprising artificial endosymbionts and methods of introducing artificial endosymbionts into eukaryotic host cells. The invention provides artificial endosymbionts that introduce a phenotype to host cells that is maintained in daughter cells. The invention additionally provides eukaryotic host cells containing magnetotactic bacteria.
    Type: Application
    Filed: September 12, 2016
    Publication date: December 29, 2016
    Applicant: Bell Biosystems, Inc.
    Inventors: Caleb Bell, III, Alexey Bazarov
  • Patent number: 9458432
    Abstract: The present invention is directed generally to eukaryotic host cells comprising artificial endosymbionts and methods of introducing artificial endosymbionts into eukaryotic host cells. The invention provides artificial endosymbionts that introduce a phenotype to host cells that is maintained in daughter cells. The invention additionally provides eukaryotic host cells containing magnetotactic bacteria.
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: October 4, 2016
    Assignee: Bell Biosystems, Inc.
    Inventors: Caleb Bell, III, Alexey Bazarov
  • Publication number: 20150267175
    Abstract: The present invention is directed generally to eukaryotic host cells comprising artificial endosymbionts and methods of introducing artificial endosymbionts into eukaryotic host cells. The invention provides artificial endosymbionts that introduce a phenotype to host cells that is maintained in daughter cells. The invention additionally provides eukaryotic host cells containing magnetotactic bacteria.
    Type: Application
    Filed: June 8, 2015
    Publication date: September 24, 2015
    Applicant: BELL BIOSYSTEMS, INC.
    Inventors: Caleb Bell, III, Alexy Bazarov
  • Publication number: 20150225687
    Abstract: The present invention is directed generally to systems for making host cells with artificial endosymbionts. In an embodiment, the systems of the invention comprise a host cell, an artificial endosymbiont, a means for introducing the artificial endosymbiont to the host cell, a means for separating the host cells with artificial endosymbionts from free artificial endosymbionts, and a means for detecting artificial endosymbionts in host cells.
    Type: Application
    Filed: February 12, 2015
    Publication date: August 13, 2015
    Inventors: Caleb Bell, III, Alexey Bazarov, Brad Rice
  • Patent number: 9085764
    Abstract: The present invention is directed generally to eukaryotic host cells comprising artificial endosymbionts and methods of introducing artificial endosymbionts into eukaryotic host cells. The invention provides artificial endosymbionts that introduce a phenotype to host cells that is maintained in daughter cells. The invention additionally provides eukaryotic host cells containing magnetotactic bacteria.
    Type: Grant
    Filed: December 24, 2014
    Date of Patent: July 21, 2015
    Assignee: Bell Biosystems, Inc.
    Inventors: Caleb Bell, III, Alexey Bazarov
  • Publication number: 20150152391
    Abstract: The present invention is directed generally to eukaryotic host cells comprising artificial endosymbionts and methods of introducing artificial endosymbionts into eukaryotic host cells. The invention provides artificial endosymbionts that introduce a phenotype to host cells that is maintained in daughter cells. The invention additionally provides eukaryotic host cells containing magnetotactic bacteria.
    Type: Application
    Filed: December 24, 2014
    Publication date: June 4, 2015
    Applicant: BELL BIOSYSTEMS, INC.
    Inventors: Caleb Bell, III, Alexy Bazarov